About this trial
The purpose of this study is to determine the effect of decreased insufflation pressure on postoperative pain, analgesic use, and surgical safety and feasibility for laparoscopic hysterectomy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Women aged 18 to 80
BMI 55.0 or less
Laparoscopic hysterectomy surgery planned
Disqualifiers
Women younger than 18 or older than 80 years of age
BMI over 55.0
Laparoscopic hysterectomy surgery not planned
Trial design
Parallel
Treatments tested in this trial
Lower Insufflation Pressure
Procedure/SurgeryParticipants underwent laparoscopic hysterectomy with an insufflation pressure that is lower than the standard insufflation pressure used in this type of surgery.
Standard Insufflation Pressure
Procedure/SurgeryParticipants underwent laparoscopic hysterectomy with a standard insufflation pressure.
Treatment groups
Trial outcomes
Primary outcomes
Pain on postoperative day 1
All participants will be asked to rate their pain using the Visual Analog Scale (VAS) approximately 24 hours after surgery completion. This scale ranges from 0 to 10, with 0 indicating no pain and 10 indicating worst possible pain.
Secondary outcomes
Preoperative pain
All participants will be asked to rate their pain using the Visual Analog Scale (VAS) upon their arrival before surgery. This scale ranges from 0 to 10, with 0 indicating no pain and 10 indicating worst possible pain.
Postoperative pain while in PACU
All participants will be asked to rate their pain using the Visual Analog Scale (VAS) while they are recovering in PACU, approximately 2 hours after surgery completion. This scale ranges from 0 to 10, with 0 indicating no pain and 10 indicating worst possible pain.
Postoperative pain at follow-up visit
All participants will be asked to rate their pain using the Visual Analog Scale (VAS) at their 2-week postoperative follow-up visit. This scale ranges from 0 to 10, with 0 indicating no pain and 10 indicating worst possible pain.
Opioid use after discharge
All participants will be asked about the number of prescription opioid pills they took following discharge.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.